BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Göbel T, Vorderwülbecke S, Hauck K, Fey H, Häussinger D, Erhardt A. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World J Gastroenterol 2006; 12(47): 7604-7612 [PMID: 17171788 DOI: 10.3748/wjg.v12.i47.7604]
URL: https://www.wjgnet.com/1948-5182/full/v12/i47/7604.htm
Number Citing Articles
1
Andrea Hodgetts, Michael Levin, J Simon Kroll, Paul R Langford. Biomarker discovery in infectious diseases using SELDIFuture Microbiology 2007; 2(1): 35 doi: 10.2217/17460913.2.1.35
2
Dan Theodorescu, Harald Mischak. Mass spectrometry based proteomics in urine biomarker discoveryWorld Journal of Urology 2007; 25(5): 435 doi: 10.1007/s00345-007-0206-3
3
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth Yanek, Karen Bornstein, Robert A. Fisher. Proteomic Analysis of HCV Cirrhosis and HCV-Induced HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver TransplantationTransplantation 2009; 87(1): 143 doi: 10.1097/TP.0b013e318191c68d
4
L. Zhong, D. Taylor, D.J. Begg, R.J. Whittington. Biomarker discovery for ovine paratuberculosis (Johne's disease) by proteomic serum profilingComparative Immunology, Microbiology and Infectious Diseases 2011; 34(4): 315 doi: 10.1016/j.cimid.2011.03.001
5
Matthew L. Cowan, Tony M. Rahman, Sanjeev Krishna. Proteomic approaches in the search for biomarkers of liver fibrosisTrends in Molecular Medicine 2010; 16(4): 171 doi: 10.1016/j.molmed.2010.01.006
6
Maria Paola Simula, Valli De Re. Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: A focus on recent advances in proteomicsPROTEOMICS - Clinical Applications 2010; 4(10-11): 782 doi: 10.1002/prca.201000049
7
Corinna Henkel, Kristina Schwamborn, Henning W. Zimmermann, Frank Tacke, Elisabeth Kühnen, Margarete Odenthal, M. Reid Groseclose, Richard M. Caprioli, Ralf Weiskirchen. From proteomic multimarker profiling to interesting proteins: thymosin-β4 and kininogen-1 as new potential biomarkers for inflammatory hepatic lesionsJournal of Cellular and Molecular Medicine 2011; 15(10): 2176 doi: 10.1111/j.1582-4934.2010.01204.x
8
Sofiya Kolusheva, Rami Yossef, Aleksandra Kugel, Nirit Hanin-Avraham, Meital Cohen, Eitan Rubin, Angel Porgador. A Novel “Reactomics” Approach for Cancer DiagnosticsSensors 2012; 12(5): 5572 doi: 10.3390/s120505572
9
Daniela Spano, Flora Cimmino, Mario Capasso, Fulvio D’Angelo, Nicola Zambrano, Luigi Terracciano, Achille Iolascon. Changes of the Hepatic Proteome in Hepatitis B-Infected Mouse Model at Early Stages of FibrosisJournal of Proteome Research 2008; 7(7): 2642 doi: 10.1021/pr7006522
10
Harald Tammen, Andrew Peck, Petra Budde, Hans-Dieter Zucht. Peptidomics analysis of human blood specimens for biomarker discoveryExpert Review of Molecular Diagnostics 2007; 7(5): 605 doi: 10.1586/14737159.7.5.605
11
Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosisInternational Journal of Biological Macromolecules 2018; 111: 379 doi: 10.1016/j.ijbiomac.2017.12.168
12
Ying Lin, William S. Dynan, Jeffrey R. Lee, Zhao-Hua Zhu, Robert R. Schade. The Current State of Proteomics in GI OncologyDigestive Diseases and Sciences 2009; 54(3): 431 doi: 10.1007/s10620-008-0656-5
13
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An OverviewAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
14
Yoshiyuki Takahara, Mitsuo Takahashi, Qing-Wei Zhang, Hirotaka Wagatsuma, Maiko Mori, Akihiro Tamori, Susumu Shiomi, Shuhei Nishiguchi. Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patientsWorld Journal of Gastroenterology 2008; 14(13): 2010-2022 doi: 10.3748/wjg.14.2010
15
Alessandra Tessitore, Agata Gaggiano, Germana Cicciarelli, Daniela Verzella, Daria Capece, Mariafausta Fischietti, Francesca Zazzeroni, Edoardo Alesse. Serum Biomarkers Identification by Mass Spectrometry in High-Mortality TumorsInternational Journal of Proteomics 2013; 2013: 1 doi: 10.1155/2013/125858
16
M.A. Karpova, S.A. Moshkovskii, I.Y. Toropygin, A.I. Archakov. Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectivesJournal of Proteomics 2010; 73(3): 537 doi: 10.1016/j.jprot.2009.09.011
17
Maria Ercibengoa, Marta Alonso. The Use of Mass Spectrometry Technology (MALDI-TOF) in Clinical Microbiology2018; : 255 doi: 10.1016/B978-0-12-814451-0.00017-4
18
Kara Rye, Robert Scott, Gerri Mortimore, Adam Lawson, Andrew Austin, Jan Freeman. Towards Noninvasive Detection of Oesophageal VaricesInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/343591
19
Abdel Aziz M. Shaheen, Robert P. Myers. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C–related fibrosis: A systematic reviewHepatology 2007; 46(3): 912 doi: 10.1002/hep.21835
20
Meital Cohen, Rami Yossef, Tamir Erez, Aleksandra Kugel, Michael Welt, Mark M. Karpasas, Jonathan Bones, Pauline M. Rudd, Julien Taieb, Herve Boissin, Dror Harats, Karin Noy, Yoram Tekoah, Rachel G. Lichtenstein, Eitan Rubin, Angel Porgador, Hana Algül. Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical AssaysPLoS ONE 2011; 6(1): e14540 doi: 10.1371/journal.pone.0014540
21
Shi-Qiang Shen, Kun Li, Neng Zhu, Akimasa Nakao. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinomaMedical Oncology 2008; 25(3): 341 doi: 10.1007/s12032-008-9042-6
22
Junjie Zhang, Fei Guo, Lei Wang, Wei Zhao, Da Zhang, Heying Yang, Jiekai Yu, Lili Niu, Fuquan Yang, Shu Zheng, Jiaxiang Wang. Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory FactorsInternational Journal of Molecular Sciences 2014; 15(9): 16186 doi: 10.3390/ijms150916186
23
Rebekka A Hannivoort, Virginia Hernandez-Gea, Scott L Friedman. Genomics and proteomics in liver fibrosis and cirrhosisFibrogenesis & Tissue Repair 2012; 5(1) doi: 10.1186/1755-1536-5-1
24
Marwa K. Ibrahim, Hosny Salama, Mohamad Abd El Rahman, Reham M. Dawood, Noha G. Bader El Din, Heba F. Salem, Mohamed E.A. Abdelrahim, Dalia Omran, Moataza H. Omran, Khaled Helmi El-Wakeel, Tawfeek H. Abdelhafez, Ahmed Khedr, Mostafa K. El Awady. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus PatientsJournal of Interferon & Cytokine Research 2016; 36(12): 698 doi: 10.1089/jir.2016.0042
25
Lauren N. Bell, Janice L. Theodorakis, Raj Vuppalanchi, Romil Saxena, Kerry G. Bemis, Mu Wang, Naga Chalasani. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver diseaseHepatology 2010; 51(1): 111 doi: 10.1002/hep.23271
26
Momar Ndao. SELDI-TOF Mass SpectrometryMethods in Molecular Biology 2012; 818: 67 doi: 10.1007/978-1-61779-418-6_5
27
Anuradha Budhu, Junfang Ji, Xin Wei Wang. Hepatocellular Carcinoma2009; : 131 doi: 10.1007/978-1-60327-376-3_5
28
Stephanie Roessler, Anuradha Budhu, Xin Wei Wang. Future of molecular profiling of human hepatocellular carcinomaFuture Oncology 2007; 3(4): 429 doi: 10.2217/14796694.3.4.429
29
Kin Jip Cheung, Kelly Tilleman, Dieter Deforce, Isabelle Colle, Hans Van Vlierberghe. Proteomics in liver fibrosis is more than meets the eyeEuropean Journal of Gastroenterology & Hepatology 2008; 20(5): 450 doi: 10.1097/MEG.0b013e3282f4de92
30
Kamlesh K. Bhopale, Samir M. Amer, Lata Kaphalia, Kizhake V. Soman, John E. Wiktorowicz, Ghulam A. Shakeel Ansari, Bhupendra S. Kaphalia. Proteomic Profiling of Liver and Plasma in Chronic Ethanol Feeding Model of Hepatic Alcohol Dehydrogenase-Deficient Deer MiceAlcoholism: Clinical and Experimental Research 2017; 41(10): 1675 doi: 10.1111/acer.13470
31
Momar Ndao, Adam Rainczuk, Marie-Claire Rioux, Terry W. Spithill, Brian J. Ward. Is SELDI-TOF a valid tool for diagnostic biomarkers?Trends in Parasitology 2010; 26(12): 561 doi: 10.1016/j.pt.2010.07.004
32
Judith Y.M.N. Engwegen, Annekatrien C.T.M. Depla, Marianne E. Smits, Annemieke Cats, Henriëtte Tuynman, Henk A. Van Heukelem, Pleun Snel, Wouter Meuleman, Lodewyk F. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at RiskBiomarker Insights 2008; 3: BMI.S790 doi: 10.4137/BMI.S790
33
Perumal Vivekanandan, Om V Singh. High-dimensional biology to comprehend hepatocellular carcinomaExpert Review of Proteomics 2008; 5(1): 45 doi: 10.1586/14789450.5.1.45
34
ShuLong Li, Xin Liu, Lai Wei, HuiFen Wang, JiYang Zhang, HanDong Wei, XiaoHong Qian, Ying Jiang, FuChu He. Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategyScience China Life Sciences 2011; 54(5): 393 doi: 10.1007/s11427-011-4165-y
35
J. O. SMITH, R. K. STERLING. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis CAlimentary Pharmacology & Therapeutics 2009; 30(6): 557 doi: 10.1111/j.1365-2036.2009.04062.x
36
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationHealth Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
37
Farid E. Ahmed. The role of capillary electrophoresis–mass spectrometry to proteome analysis and biomarker discoveryJournal of Chromatography B 2009; 877(22): 1963 doi: 10.1016/j.jchromb.2009.05.023